Stock Information
Pharvaris NV (PHVS)
Ticker Symbol: PHVS
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,553.98 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -2.9185
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -66.17%
Latest News
-
Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology
Fri, Mar 20, 2026 10:50 AM
-
Pharvaris Announces Publication Of Data From Two Randomized Phase 2 Studies, CHAPTER-1 And RAPIDe-1, Evaluating Efficacy And Safety Of Deucrictibant For Prophylaxis And On-Demand Treatment Of HAE Attacks, In The Lancet Haematology
Fri, Mar 20, 2026 6:53 AM
-
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
Wed, Mar 18, 2026 6:08 PM
-
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
Wed, Mar 18, 2026 5:54 PM
Key Financials
Financial data not available
